Search

Manomi Anupama Tennakoon

from New Hope, PA
Age ~49
Get Report
Also known as:
Manomi A Tennakoon, Menom Tennakoon, I Tennakoon
Connected to:
Chaminda A Tennakoon, 51Aaron E Tennant, 52Aleen J Tennant, 66Alyson K Tennant, 36Amie J Tennant, 41Andora M Tennant, 50Angela D Tennant, 50Ardith L Tennant, 71Aubrey A Tennant, 28Barrett H Tennant, 48

Manomi Tennakoon Phones & Addresses

  • New Hope, PA
  • 65 Meadowbrook Dr, Hillsborough, NJ 08844 (908) 359-5914
  • 1004 Donegal Dr, Bridgewater, NJ 08807
  • Minneapolis, MN
  • Raritan, NJ
  • Morristown, NJ
  • New York, NY

Work

Company: Johnson & johnson Jun 2017 Position: Director, north american regulatory liaison, janssen research and development

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Minnesota 1996 to 2001 Specialities: Chemistry

Skills

Drug Discovery • Clinical Trials • Drug Development • Chemistry • Pharmaceutical Industry • Regulatory Submissions • Medicinal Chemistry • Organic Chemistry • In Vitro • Therapeutic Areas • Biotechnology • Clinical Development • Regulatory Affairs • Pharmaceutics • Lifesciences • In Vivo • Assay Development

Industries

Pharmaceuticals

Resumes

Resumes

Manomi Tennakoon Photo 1

Director, North American Regulatory Liaison, Janssen Research And Development

View page
Location:
4198 Greenspire Ln, New Hope, PA 18938
Industry:
Pharmaceuticals
Work:
Johnson & Johnson
Director, North American Regulatory Liaison, Janssen Research and Development
Johnson & Johnson Sep 2013 - Jun 2017
Associate Director, North American Regulatory Liaison
Johnson & Johnson Apr 2009 - Sep 2013
Manager - Clinical Trial Regulatory Leader and Regulatory Professional
Johnson & Johnson Sep 2001 - Apr 2009
Scientist and Senior Scientist, Drug Discovery, Pharmaceutical Research and Development
University of Minnesota 1996 - 2001
Phd, Synthetic Orgranic Chemistry
Education:
University of Minnesota 1996 - 2001
Doctorates, Doctor of Philosophy, Chemistry College of Saint Elizabeth 1992 - 1996
Bachelors, Bachelor of Science, Chemistry
Skills:
Drug Discovery
Clinical Trials
Drug Development
Chemistry
Pharmaceutical Industry
Regulatory Submissions
Medicinal Chemistry
Organic Chemistry
In Vitro
Therapeutic Areas
Biotechnology
Clinical Development
Regulatory Affairs
Pharmaceutics
Lifesciences
In Vivo
Assay Development

Publications

Us Patents

Antimicrobial Oxazolidinone Prodrugs

View page
US Patent:
7776855, Aug 17, 2010
Filed:
Jul 9, 2007
Appl. No.:
11/774746
Inventors:
Mark J. Macielag - Branchburg NJ, US
Manomi A. Tennakoon - Hillsborough NJ, US
Assignee:
Janssen Pharmaceutica N.V. - Beerse
International Classification:
A61K 31/42
A61K 31/497
C07D 263/04
C07D 403/00
C07D 413/14
US Classification:
5142342, 51425402, 514376, 544137, 544370, 548229
Abstract:
This invention includes oxazolidinone prodrug compounds of Formula (I) and Formula (II) as defined herein. The prodrugs are convertible by natural biological processes into an active ingredient possessed of antimicrobial properties useful in treating bacterial infections in mammals.

6-O-Acyl Ketolide Antibacterials

View page
US Patent:
20030220272, Nov 27, 2003
Filed:
Nov 21, 2002
Appl. No.:
10/301412
Inventors:
Todd Henninger - High Bridge NJ, US
Mark Macielag - Branchburg NJ, US
Manomi Tennakoon - Bridgewater NJ, US
Xiaodong Xu - Bridgewater NJ, US
International Classification:
A61K031/7048
A61K031/7052
C07H017/08
US Classification:
514/029000, 536/007400, 536/017400
Abstract:
6-O-Acyl ketolide antibacterials of the formula: wherein R, R, R, R, W, X, X′, Y, and Y′ are as described herein and in which the substituents have the meaning indicated in the description. These compounds are useful as antibacterial agents.

3-Hydrazone Piperazinyl Rifamycin Derivatives Useful As Antimicrobial Agents

View page
US Patent:
20090275594, Nov 5, 2009
Filed:
May 4, 2009
Appl. No.:
12/434832
Inventors:
Mark J. MACIELAG - Branchburg NJ, US
Manomi Tennakoon - Hillsborough NJ, US
International Classification:
A61K 31/496
C07D 413/14
A61P 31/04
US Classification:
5142531, 544367, 51425404, 544364
Abstract:
The present invention is directed to novel 3-hydrazone piperazinyl rifamycin derivatives, pharmaceutical compositions containing them and the use of said derivatives and pharmaceutical compositions as antimicrobial agents against pathogenic microorganisms, particularly against resistant microbes.

3-(Substituted Ethyl)-Rifamycin Derivatives Useful As Antimicrobial Agents

View page
US Patent:
20100029669, Feb 4, 2010
Filed:
Jul 14, 2009
Appl. No.:
12/502435
Inventors:
Mark J. MACIELAG - Branchburg NJ, US
Manomi A. Tennakoon - Hillsborough NJ, US
International Classification:
A61K 31/395
C07D 498/06
A61K 31/496
A61K 31/501
A61P 31/04
US Classification:
51425201, 540458, 514450, 51425411
Abstract:
The present invention is directed to novel 3-(substituted ethyl) rifamycin derivatives, pharmaceutical compositions containing them and the use of said derivatives and pharmaceutical compositions as antimicrobial agents against pathogenic microorganisms, particularly against resistant microbes.

Novel Rifamycin 3,4-(3-Substituted Aminomethyl) Fused Pyrrolo Derivatives

View page
US Patent:
20100152267, Jun 17, 2010
Filed:
Nov 3, 2009
Appl. No.:
12/611316
Inventors:
Mark J. MACIELAG - Branchburg NJ, US
Manomi A. Tennakoon - Hillsborough NJ, US
International Classification:
A61K 31/407
C07D 498/06
US Classification:
514410, 540457
Abstract:
The present invention is directed to novel 3,4-(3′-substituted aminomethyl) fused pyrrolo rifamyacin derivatives, pharmaceutical compositions containing them and the use of said derivatives and pharmaceutical compositions as antimicrobial agents against pathogenic microorganisms, particularly against resistant microbes.
Control profile
Manomi Anupama Tennakoon from New Hope, PA, age ~49 Get Report